ZBTB46 and prostate cancer: The mean expression correlation was analyzed in prostate cancer datasets, which showed that CHRM4 was positively correlated with NGF, ZBTB46 (Fig. 6g), and neuroendocrine marker expressions and inversely correlated with androgen-responsive gene expressions (Fig. 6h).